Powles T, et al. A phase II study investigating the safety and efficacy of savolitinib and durvalumab in metastatic papillary renal cancer (CALYPSO). ASCO-GU 2019, abstract 545.
ASCO GI 2020: nieuwe GE-behandelingen gepaard met betere kwaliteit van leven
apr 2020 | Maag-darm-leveroncologie